The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond
Open accessAbstract
Epilepsy is one of the most common and disabling chronic neurological disorders. Antiseizure medications (ASMs), previously referred to as anticonvulsant or antiepileptic drugs, are the mainstay of symptomatic epilepsy treatment. Epilepsy is a multifaceted complex disease and so is its treatment. Currently, about 30 ASMs are available for epilepsy therapy. Furthermore, several ASMs are approved therapies in nonepileptic conditions, including neuropathic pain, migraine, bipolar disorder, and generalized anxiety disorder. Because of this wide spectrum of therapeutic activity, ASMs are among the most often prescribed centrally active agents. Most ASMs act by modulation of voltage-gated ion channels; by enhancement of gamma aminobutyric acid-mediated inhibition; through interactions with elements of the synaptic release machinery; by blockade of ionotropic glutamate receptors; or by combinations of these mechanisms. Because of differences in their mechanisms of action, most ASMs do not suppress all types of seizures, so appropriate treatment choices are important. The goal of epilepsy therapy is the complete elimination of seizures; however, this is not achievable in about one-third of patients. Both in vivo and in vitro models of seizures and epilepsy are used to discover ASMs that are more effective in patients with continued drug-resistant seizures. Furthermore, therapies that are specific to epilepsy etiology are being developed. Currently, ~ 30 new compounds with diverse antiseizure mechanisms are in the preclinical or clinical drug development pipeline. Moreover, therapies with potential antiepileptogenic or disease-modifying effects are in preclinical and clinical development. Overall, the world of epilepsy therapy development is changing and evolving in many exciting and important ways. However, while new epilepsy therapies are developed, knowledge of the pharmacokinetics, antiseizure efficacy and spectrum, and adverse effect profiles of currently used ASMs is an essential component of treating epilepsy successfully and maintaining a high quality of life for every patient, particularly those receiving polypharmacy for drug-resistant seizures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Simple Practice Guide for Dose Conversion between Animals and Human
Nair, A., & Jacob, S. (2016) · Journal of Basic and Clinical Pharmacy · doi:10.4103/0976-0105.177703 · Cited by 6,174
Early Identification of Refractory Epilepsy
Kwan, P., & Brodie, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420503 · Cited by 5,204
Scheffer, I. E., Berkovic, S., Capovilla, G., Connolly, M. B., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Moshé, S. L., et al. (2017) · Epilepsia · doi:10.1111/epi.13709 · Cited by 5,054
Fisher, R. S., Cross, J. H., French, J. A., Higurashi, N., Hirsch, E., Jansen, F. E., Lagae, L., Moshé, S. L., Peltola, J., Roulet Perez, E., et al. (2017) · Epilepsia · doi:10.1111/epi.13670 · Cited by 3,483
Chen, Z., Brodie, M. J., Liew, D., & Kwan, P. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3949 · Cited by 1,514
Glauser, T., Shinnar, S., Gloss, D., Alldredge, B., Arya, R., Bainbridge, J., Bare, M., Bleck, T., Dodson, W. E., Garrity, L., et al. (2016) · Epilepsy Currents · doi:10.5698/1535-7597-16.1.48 · Cited by 1,280
The neurobiology of antiepileptic drugs
Rogawski, M. A., & Löscher, W. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1430 · Cited by 1,239
Self-citationPatsalos, P. N., Berry, D. J., Bourgeois, B. F. D., Cloyd, J. C., Glauser, T. A., Johannessen, S. I., Leppik, I. E., Tomson, T., & Perucca, E. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01561.x · Cited by 1,156
Devinsky, O., Vezzani, A., O'Brien, T. J., Jette, N., Scheffer, I. E., de Curtis, M., & Perucca, P. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.24 · Cited by 959
Recommendation for a definition of acute symptomatic seizure
Beghi, E., Carpio, A., Forsgren, L., Hesdorffer, D. C., Malmgren, K., Sander, J. W., Tomson, T., & Hauser, W. A. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02285.x · Cited by 924
Löscher, W., Potschka, H., Sisodiya, S. M., & Vezzani, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019539 · Cited by 903
Self-citationLöscher, W., & Schmidt, D. (1988) · Epilepsy Research · doi:10.1016/0920-1211(88)90054-x · Cited by 806
Self-citationGlauser, T., Ben‐Menachem, E., Bourgeois, B., Cnaan, A., Chadwick, D., Guerreiro, C., Kalviainen, R., Mattson, R., Perucca, E., & Tomson, T. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00585.x · Cited by 790
French, J. A., Lawson, J. A., Yapici, Z., Ikeda, H., Polster, T., Nabbout, R., Curatolo, P., de Vries, P. J., Dlugos, D. J., Berkowitz, N., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31419-2 · Cited by 764
Wasterlain, C. G. (1990) · Cited by 741
Glauser, T., Ben‐Menachem, E., Bourgeois, B., Cnaan, A., Guerreiro, C., Kälviäinen, R., Mattson, R., French, J. A., Perucca, E., Tomson, T., et al. (2013) · Epilepsia · doi:10.1111/epi.12074 · Cited by 721
New avenues for anti-epileptic drug discovery and development
Löscher, W., Klitgaard, H., Twyman, R. E., & Schmidt, D. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4126 · Cited by 675
Self-citationEthosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy
Glauser, T. A., Cnaan, A., Shinnar, S., Hirtz, D. G., Dlugos, D., Masur, D., Clark, P. O., Capparelli, E. V., & Adamson, P. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0902014 · Cited by 645
Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma
Löscher, W., & Schmidt, D. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03024.x · Cited by 590
Self-citationModels of Seizures and Epilepsy
(2006) · Elsevier eBooks · doi:10.1016/b978-0-12-088554-1.x5000-2 · Cited by 561
Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus
Kapur, J., Elm, J., Chamberlain, J. M., Barsan, W., Cloyd, J., Lowenstein, D., Shinnar, S., Conwit, R., Meinzer, C., Cock, H., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1905795 · Cited by 551
Antiepileptic Drugs as a Cause of Worsening Seizures
Perucca, E., Gram, L., Avanzini, G., & Dulac, O. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01268.x · Cited by 543
Key factors in the discovery and development of new antiepileptic drugs
Bialer, M., & White, H. S. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2997 · Cited by 542
Mechanisms of action of currently used antiseizure drugs
Sills, G. J., & Rogawski, M. A. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107966 · Cited by 489
Therapeutic Drug Monitoring of Antiepileptic Drugs in Epilepsy: A 2018 Update
Patsalos, P. N., Spencer, E. P., & Berry, D. J. (2018) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000546 · Cited by 477
Cruccu, G., Di Stefano, G., & Truini, A. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1914484 · Cited by 464
The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions
Rogawski, M. A., & Löscher, W. (2004) · Nature Medicine · doi:10.1038/nm1074 · Cited by 456
Self-citationManagement of psychiatric and neurological comorbidities in epilepsy
Kanner, A. M. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.243 · Cited by 451
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
Garakani, A., Murrough, J. W., Freire, R. C., Thom, R. P., Larkin, K., Buono, F. D., & Iosifescu, D. V. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.595584 · Cited by 440
Etiology and Pharmacology of Neuropathic Pain
Alles, S. R. A., & Smith, P. A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014399 · Cited by 395
Lagae, L., Sullivan, J., Knupp, K., Laux, L., Polster, T., Nikanorova, M., Devinsky, O., Cross, J. H., Guerrini, R., Talwar, D., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32500-0 · Cited by 384
Lamotrigine substitution study: evidence for synergism with sodium valproate?
Brodie, M. J., & Yuen, A. W. C. (1997) · Epilepsy Research · doi:10.1016/s0920-1211(96)01007-8 · Cited by 379
Sen, A., Jette, N., Husain, M., & Sander, J. W. (2020) · The Lancet · doi:10.1016/s0140-6736(19)33064-8 · Cited by 369
Löscher, W. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2222-z · Cited by 367
Self-citationNeonatal Hypoxia Ischaemia: Mechanisms, Models, and Therapeutic Challenges
Millar, L. J., Shi, L., Hoerder-Suabedissen, A., & Molnár, Z. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00078 · Cited by 348
Krauss, G. L., Klein, P., Brandt, C., Lee, S. K., Milanov, I., Milovanovic, M., Steinhoff, B. J., & Kamin, M. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30399-0 · Cited by 342
Self-citationManagement of refractory status epilepticus in adults: still more questions than answers
Rossetti, A. O., & Lowenstein, D. H. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70187-9 · Cited by 341
Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet
Rogawski, M. A., Löscher, W., & Rho, J. M. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a022780 · Cited by 336
Self-citationSelection of Antiepileptic Drug Polytherapy Based on Mechanisms of Action: The Evidence Reviewed
Deckers, C. L. P., Czuczwar, S. J., Hekster, Y. A., Kewser, A., Kubova, H., Meinardi, H., Patsalos, P. N., Renier, W. O., & Van Rijn, C. M. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00111.x · Cited by 331
Kindling: basic mechanisms and clinical validity
Sato, M., Racine, R. J., & McIntyre, D. C. (1990) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(90)90099-6 · Cited by 314
Experimental Determination of the Anticonvulsant Properties of Some Phenyl Derivatives
Putnam, T. J., & Merritt, H. H. (1937) · Science · doi:10.1126/science.85.2213.525 · Cited by 306
Löscher, W., & Hönack, D. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90768-d · Cited by 281
Self-citationTeratogenic effects of antiepileptic drugs
Tomson, T., & Battino, D. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70103-5 · Cited by 271
Tomson, T., Battino, D., & Perucca, E. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00314-2 · Cited by 266
Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial
Kotulska, K., Kwiatkowski, D. J., Curatolo, P., Weschke, B., Riney, K., Jansen, F., Feucht, M., Krsek, P., Nabbout, R., Jansen, A. C., et al. (2021) · Annals of Neurology · doi:10.1002/ana.25956 · Cited by 265
30 years of second-generation antiseizure medications: impact and future perspectives
Perucca, E., Brodie, M. J., Kwan, P., & Tomson, T. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30035-1 · Cited by 261
Chagas, M. H. N., Eckeli, A. L., Zuardi, A. W., Pena-Pereira, M. A., Sobreira-Neto, M. A., Sobreira, E. T., Camilo, M. R., Bergamaschi, M. M., Schenck, C. H., Hallak, J. E. C., et al. (2014) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12179 · Cited by 253
Monotherapy or Polytherapy for Epilepsy?
Guberman, A. (1998) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100034892 · Cited by 252
Nabbout, R., Mistry, A., Zuberi, S., Villeneuve, N., Gil-Nagel, A., Sanchez-Carpintero, R., Stephani, U., Laux, L., Wirrell, E., Knupp, K., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2019.4113 · Cited by 251
Pisani, F., Oteri, G., Russo, M. F., Di Perri, R., Perucca, E., & Richens, A. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00832.x · Cited by 247
Monotherapy or Poly therapy for Epilepsy?
Reynolds, E. H., & Shorvon, S. D. (1981) · Epilepsia · doi:10.1111/j.1528-1157.1981.tb04327.x · Cited by 244
Combining antiepileptic drugs—Rational polytherapy?
Brodie, M. J., & Sills, G. J. (2011) · Seizure · doi:10.1016/j.seizure.2011.01.004 · Cited by 244
Löscher, W., & Schmidt, D. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00607.x · Cited by 239
Self-citationChamberlain, J. M., Kapur, J., Shinnar, S., Elm, J., Holsti, M., Babcock, L., Rogers, A., Barsan, W., Cloyd, J., Lowenstein, D., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30611-5 · Cited by 238
McTague, A., Martland, T., & Appleton, R. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001905.pub3 · Cited by 237
A Clinical Overview of Off-label Use of Gabapentinoid Drugs
Goodman, C. W., & Brett, A. S. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.0086 · Cited by 230
Löscher, W., & Friedman, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020591 · Cited by 229
Self-citationLöscher, W., & Schmidt, D. (1994) · Epilepsy Research · doi:10.1016/0920-1211(94)90012-4 · Cited by 221
Self-citationSilverstein, F. S., & Jensen, F. E. (2007) · Annals of Neurology · doi:10.1002/ana.21167 · Cited by 218
Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial
Sharpe, C., Reiner, G. E., Davis, S. L., Nespeca, M., Gold, J. J., Rasmussen, M., Kuperman, R., Harbert, M. J., Michelson, D., Joe, P., et al. (2020) · Pediatrics · doi:10.1542/peds.2019-3182 · Cited by 207
Kanner, A. M., Ashman, E., Gloss, D., Harden, C., Bourgeois, B., Bautista, J. F., Abou-Khalil, B., Burakgazi-Dalkilic, E., Llanas Park, E., Stern, J., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005755 · Cited by 205
Seizure cluster: Definition, prevalence, consequences, and management
Jafarpour, S., Hirsch, L. J., Gaínza-Lein, M., Kellinghaus, C., & Detyniecki, K. (2019) · Seizure · doi:10.1016/j.seizure.2018.05.013 · Cited by 196
Febrile Seizures: Risks, Evaluation, and Prognosis.
Smith, D. K., Sadler, K. P., & Benedum, M. (2019) · PubMed · Cited by 194
Drug development for refractory epilepsy: The past 25 years and beyond
Golyala, A., & Kwan, P. (2017) · Seizure · doi:10.1016/j.seizure.2016.11.022 · Cited by 188
Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond
Löscher, W., Gillard, M., Sands, Z. A., Kaminski, R. M., & Klitgaard, H. (2016) · CNS Drugs · doi:10.1007/s40263-016-0384-x · Cited by 184
Self-citationPrecision medicine and therapies of the future
Sisodiya, S. M. (2020) · Epilepsia · doi:10.1111/epi.16539 · Cited by 184
Combination Therapy in Epilepsy: When and What to Use
Kwan, P., & Brodie, M. J. (2006) · Drugs · doi:10.2165/00003495-200666140-00004 · Cited by 183
Pharmacoresistance – Epidemiology, mechanisms, and impact on epilepsy treatment
Janmohamed, M., Brodie, M. J., & Kwan, P. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107790 · Cited by 183
Why are antiepileptic drugs used for nonepileptic conditions?
Bialer, M. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03712.x · Cited by 174
Klitgaard, H., Matagne, A., Nicolas, J., Gillard, M., Lamberty, Y., De Ryck, M., Kaminski, R. M., Leclercq, K., Niespodziany, I., Wolff, C., et al. (2016) · Epilepsia · doi:10.1111/epi.13340 · Cited by 168
Löscher, W. (2016) · Epilepsy Research · doi:10.1016/j.eplepsyres.2016.05.016 · Cited by 164
Self-citationModels of seizures and epilepsy
V. Patwardhan, R. (2006) · Surgical Neurology · doi:10.1016/j.surneu.2005.11.046 · Cited by 161
Kehne, J. H., Klein, B. D., Raeissi, S. D., & Sharma, S. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2275-z · Cited by 160
Bialer, M., Johannessen, S. I., Koepp, M. J., Levy, R. H., Perucca, E., Perucca, P., Tomson, T., & White, H. S. (2020) · Epilepsia · doi:10.1111/epi.16725 · Cited by 149
Seizure clusters: characteristics and treatment
Haut, S. R. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000177 · Cited by 147
The holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments
Löscher, W. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.04.011 · Cited by 144
Self-citationPregabalin for the treatment of generalized anxiety disorder: an update
Baldwin, D. S., Ajel, Nowak, Rafiq, & Masdrakis, V. G. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s36453 · Cited by 143
Infantile Spasms: Outcome in Clinical Studies
Riikonen, R. (2020) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2020.01.015 · Cited by 143
Adverse effects of antiepileptic drugs
Perucca, E., & Meador, K. J. (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00506.x · Cited by 142
Use of Antiepileptic Drugs in the Treatment of Chronic Painful Diabetic Neuropathy
Vinik, A. I. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2376 · Cited by 140
Costa, J. N., Fareleira, F., Ascenção, R. M. S. E. S., Borges, M., Sampaio, C., & Carneiro, A. V. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03047.x · Cited by 138
Bialer, M., Johannessen, S. I., Koepp, M. J., Levy, R. H., Perucca, E., Tomson, T., & White, H. S. (2018) · Epilepsia · doi:10.1111/epi.14557 · Cited by 137
Current position of phenobarbital in epilepsy and its future
Brodie, M. J., & Kwan, P. (2012) · Epilepsia · doi:10.1111/epi.12027 · Cited by 132
Dravet syndrome: Treatment options and management of prolonged seizures
Cross, J. H., Caraballo, R. H., Nabbout, R., Vigevano, F., Guerrini, R., & Lagae, L. G. (2019) · Epilepsia · doi:10.1111/epi.16334 · Cited by 132
Dravet Syndrome: A Review of Current Management
Wheless, J. W., Fulton, S. P., & Mudigoudar, B. D. (2020) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2020.01.005 · Cited by 126
Current and Emerging Pharmacotherapy for Fibromyalgia
Tzadok, R., & Ablin, J. N. (2020) · Pain Research and Management · doi:10.1155/2020/6541798 · Cited by 122
Acth treatment of infantile spasms: Mechanisms of its effects in modulation of neuronal excitability
Brunson, K. L., Avishai‐Eliner, S., & Baram, T. Z. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)49013-7 · Cited by 118
Antiepileptic Drugs and Liver Disease
Vidaurre, J. A., Gedela, S., & Yarosz, S. (2017) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2017.09.013 · Cited by 115
Aggravation of epilepsy by anti-epileptic drugs
Gayatri, N., & Livingston, J. (2006) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162206000843 · Cited by 114
Antiepileptic drugs: detection, quantification, and evaluation.
Swinyard, E. A., & Hj, K. (1985) · PubMed · Cited by 114
The Management of Refractory Status Epilepticus: An Update
Lowenstein, D. H. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00658.x · Cited by 113
Anxioselective anxiolytics: on a quest for the Holy Grail
Skolnick, P. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.08.003 · Cited by 111
Löscher, W., Rundfeldt, C., & Hönack, D. (1993) · Epilepsy Research · doi:10.1016/0920-1211(93)90058-f · Cited by 106
Self-citationAggravation of Epilepsy By Antiepileptic Drugs
Sazgar, M., & Bourgeois, B. F. D. (2005) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2005.03.001 · Cited by 104
Recent Advances in the Drug Treatment of Dravet Syndrome
Wirrell, E. C., & Nabbout, R. (2019) · CNS Drugs · doi:10.1007/s40263-019-00666-8 · Cited by 93
Wilcox, K. S., West, P. J., & Metcalf, C. S. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107811 · Cited by 91
The pharmacological management of Lennox-Gastaut syndrome and critical literature review
Verrottı, A., Striano, P., Iapadre, G., Zagaroli, L., Bonanni, P., Coppola, G., Elia, M., Mecarelli, O., Franzonı, E., Liso, P. D., et al. (2018) · Seizure · doi:10.1016/j.seizure.2018.10.016 · Cited by 89
Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives
Donovan, M. D., Griffin, B. T., Kharoshankaya, L., Cryan, J. F., & Boylan, G. B. (2016) · Drugs · doi:10.1007/s40265-016-0554-7 · Cited by 88
Mechanisms of action of antiseizure drugs
Porter, R. J., Dhir, A., Macdonald, R. L., & Rogawski, M. A. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52899-5.00021-6 · Cited by 87
Mei, D., Cetica, V., Marini, C., & Guerrini, R. (2019) · Epilepsia · doi:10.1111/epi.16054 · Cited by 86
Antiepileptic monotherapy in newly diagnosed focal epilepsy. A network meta-analysis
Lattanzi, S., Zaccara, G., Giovannelli, F., Grillo, E., Nardone, R., Silvestrini, M., Trinka, E., & Brigo, F. (2018) · Acta Neurologica Scandinavica · doi:10.1111/ane.13025 · Cited by 85
Guignet, M. A., Campbell, A., & White, H. S. (2020) · Epilepsia · doi:10.1111/epi.16718 · Cited by 83
Pharmacodynamic interactions of antiepileptic drugs: From bench to clinical practice
Verrotti, A., Lattanzi, S., Brigo, F., & Zaccara, G. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2020.106939 · Cited by 82
Hyponatremia induced by antiepileptic drugs in patients with epilepsy
Lu, X., & Wang, X. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1248399 · Cited by 78
Rundfeldt, C., & Löscher, W. (2013) · CNS Drugs · doi:10.1007/s40263-013-0129-z · Cited by 77
Self-citationWhat has been the impact of new drug treatments on epilepsy?
Chen, Z. Z., Brodie, M. J., & Kwan, P. (2020) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000803 · Cited by 77
Current Status of Antiepileptic Drugs as Preventive Migraine Therapy
Parikh, S. K., & Silberstein, S. D. (2019) · Current Treatment Options in Neurology · doi:10.1007/s11940-019-0558-1 · Cited by 76
Hyperpolarization-Activated Cyclic Nucleotide-Gated (HCN) Channels in Epilepsy
Brennan, G. P., Baram, T. Z., & Poolos, N. P. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a022384 · Cited by 75
Do preclinical seizure models preselect certain adverse effects of antiepileptic drugs
Meldrum, B. S. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00066-9 · Cited by 71
The ups and downs of alkyl‐carbamates in epilepsy therapy: How does cenobamate differ?
Löscher, W., Sills, G. J., & White, H. S. (2021) · Epilepsia · doi:10.1111/epi.16832 · Cited by 71
Self-citationAntiepileptic drugs: evolution of our knowledge and changes in drug trials
Perucca, E. (2019) · Epileptic Disorders · doi:10.1684/epd.2019.1083 · Cited by 69
Overwater, I. E., Rietman, A. B., van Eeghen, A. M., & de Wit, M. Y. (2019) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s145630 · Cited by 68
Update on Drug Management of Refractory Epilepsy in Tuberous Sclerosis Complex
Clement, E. A. V. D. P., Jansen, F. E., Braun, K. P. J., & Peters, J. M. (2020) · Pediatric Drugs · doi:10.1007/s40272-019-00376-0 · Cited by 67
Bialer, M., & Perucca, E. (2020) · Epilepsia · doi:10.1111/epi.16542 · Cited by 66
Antiepileptic drugs in development pipeline: A recent update
Kaur, H., Kumar, B., & Medhi, B. (2016) · eNeurologicalSci · doi:10.1016/j.ensci.2016.06.003 · Cited by 64
From molecules to medicines: the dawn of targeted therapies for genetic epilepsies
Demarest, S., & Brooks‐Kayal, A. R. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0099-3 · Cited by 64
No prevention or cure of epilepsy as yet
Klein, P., & Tyrlíková, I. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107762 · Cited by 60
Self-citationBialer, M., Johannessen, S. I., Koepp, M. J., Levy, R. H., Perucca, E., Perucca, P., Tomson, T., & White, H. S. (2020) · Epilepsia · doi:10.1111/epi.16726 · Cited by 60
Molecular Therapies for Tuberous Sclerosis and Neurofibromatosis
Franz, D. N., & Weiss, B. D. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0269-4 · Cited by 58
Perampanel—new promise for refractory epilepsy?
Löscher, W., & Schmidt, D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.222 · Cited by 58
Self-citationNeurodevelopmental Effects of Antiepileptic Drugs
Kellogg, M. A., & Meador, K. J. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2262-4 · Cited by 57
Adenosine kinase: A key regulator of purinergic physiology
Boison, D., & Jarvis, M. F. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114321 · Cited by 57
Aggravation of Generalized Epilepsies
Berkovic, S. F. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb05115.x · Cited by 50
A viewpoint on rational and irrational fixed-drug combinations
Błaszczyk, B., Miziak, B., Czuczwar, P., Wierzchowska-Cioch, E., Pluta, R. M., & Czuczwar, S. J. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1500895 · Cited by 48
Current and Emerging Treatments of Essential Tremor
Ondo, W. G. (2020) · Neurologic Clinics · doi:10.1016/j.ncl.2020.01.002 · Cited by 48
Epilepsy: key experimental therapeutics in early clinical development
Steriade, C., French, J. A., & Devinsky, O. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1743678 · Cited by 48
Seizure clusters, rescue treatments, seizure action plans: Unmet needs and emerging formulations
Gidal, B. E., Klein, P., & Hirsch, L. J. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2020.107391 · Cited by 48
Self-citationZonisamide for the Treatment of Parkinson Disease: A Current Update
Li, C., Li, X., Liu, Y., Yang, Z., Chi, S., & Xie, A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.574652 · Cited by 48
Shorvon, S. D. (2009) · Wiley eBooks · doi:10.1002/9781444316667 · Cited by 47
Current concepts on epilepsy management in tuberous sclerosis complex
Canevini, M. P., Kotulska, K., Curatolo, P., Briola, F. L., Peron, A., Słowińska, M., Strzelecka, J., Vignoli, A., & Jóźwiak, S. (2018) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31652 · Cited by 47
Epilepsy, Antiseizure Therapy, and Sleep Cycle Parameters
Shvarts, V., & Chung, S. S. (2013) · Epilepsy Research and Treatment · doi:10.1155/2013/670682 · Cited by 46
An explorative literature review of the multifactorial causes of osteoporosis in epilepsy
Diemar, S. S., Sejling, A., Eiken, P., Andersen, N. B., & Jørgensen, N. R. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.106511 · Cited by 46
Seizure freedom as an outcome in epilepsy treatment clinical trials
Halford, J. J., & Edwards, J. C. (2020) · Acta Neurologica Scandinavica · doi:10.1111/ane.13257 · Cited by 46
Use of epileptic animals for adverse effect testing
Klitgaard, H., Matagne, A., & Lamberty, Y. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00068-2 · Cited by 45
Some treatments cause seizure aggravation in idiopathic epilepsies (especially absence epilepsy)
Somerville, E. R. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02233.x · Cited by 45
Non-Dopaminergic Treatments for Motor Control in Parkinson’s Disease: An Update
González-Latapí, P., Bhowmick, S. S., Saranza, G., & Fox, S. H. (2020) · CNS Drugs · doi:10.1007/s40263-020-00754-0 · Cited by 45
Boon, P., Santos, S. F., Jansen, A., Lagae, L. G., Legros, B., & Weckhuysen, S. (2020) · Acta Neurologica Belgica · doi:10.1007/s13760-020-01488-y · Cited by 45
From clinical trials of antiepileptic drugs to treatment
Perucca, E. (2018) · Epilepsia Open · doi:10.1002/epi4.12239 · Cited by 44
Campos, M. S. D. A., Ayres, L. R., Siani-Morello, M. R., Carizio, F. A. M., & Pereira, L. R. L. (2018) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-018-0641-9 · Cited by 43
Modifying genetic epilepsies – Results from studies on tuberous sclerosis complex
Jóźwiak, S., Kotulska, K., Wong, M., & Bebin, M. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107908 · Cited by 43
Hu, Q., Zhang, F., Teng, W., Hao, F., Zhang, J., Yin, M., & Wang, N. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8621-x · Cited by 41
Klein, P., Tolbert, D. S., & Gidal, B. E. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.106459 · Cited by 40
Self-citationBrodie, M. J. (2017) · CNS Drugs · doi:10.1007/s40263-016-0406-8 · Cited by 39
Modeling genetic epilepsies in a dish
Niu, W., & Parent, J. M. (2019) · Developmental Dynamics · doi:10.1002/dvdy.79 · Cited by 39
Acute Symptomatic Seizures and Provoked Seizures: to Treat or Not to Treat?
Gunawardane, N., & Fields, M. C. (2018) · Current Treatment Options in Neurology · doi:10.1007/s11940-018-0525-2 · Cited by 38
Gao, L., Li, X., Zhao, F.-L., & Li, S. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.06.005 · Cited by 36
Treatment of epilepsy in adults
Burakgazi, E., & French, J. A. (2016) · Epileptic Disorders · doi:10.1684/epd.2016.0836 · Cited by 36
Schidlitzki, A., Bascuñana, P., Srivastava, P. K., Welzel, L., Twele, F., Töllner, K., Käufer, C., Gericke, B., Feleke, R., Meier, M., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104664 · Cited by 35
Self-citationSommerfeld-Klatta, K., Zielińska‐Psuja, B., Karaźniewicz‐Łada, M., & Główka, F. K. (2020) · Molecules · doi:10.3390/molecules25215083 · Cited by 35
Pharmacologic and Nonpharmacologic Treatment of Restless Legs Syndrome
Anguelova, G. V., Vlak, M. H. M., Kurvers, A. G. Y., & Rijsman, R. M. (2020) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2020.02.013 · Cited by 32
Selection of Antiepileptic Drugs in Adults
Stephen, L. J., & Brodie, M. J. (2009) · Neurologic Clinics · doi:10.1016/j.ncl.2009.06.007 · Cited by 30
What New Modeling Approaches Will Help Us Identify Promising Drug Treatments?
Baraban, S. C., & Löscher, W. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-8914-1_23 · Cited by 29
Self-citationWelzel, L., Bergin, D. H., Schidlitzki, A., Twele, F., Johne, M., Klein, P., & Löscher, W. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105227 · Cited by 28
Self-citationTrenité, D. G. A. K.-N., Groenwold, R. H. H., Schmidt, B., & Löscher, W. (2016) · Epilepsy Research · doi:10.1016/j.eplepsyres.2016.02.003 · Cited by 27
Self-citationmTOR Inhibitors in Children: Current Indications and Future Directions in Neurology
Jeong, A., & Wong, M. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-016-0708-8 · Cited by 27
Porter, R. J., & Kupferberg, H. J. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2215-y · Cited by 27
The path from scientific discovery to cures for epilepsy
Carvill, G. L., Dulla, C. G., Lowenstein, D. H., & Brooks‐Kayal, A. R. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107702 · Cited by 23
Truini, A. (2015) · The Journal of Headache and Pain · doi:10.1186/1129-2377-16-s1-a42 · Cited by 22
Drug treatment strategies for epilepsy revisited: starting early or late? One drug or several drugs?
Schmidt, D. (2016) · Epileptic Disorders · doi:10.1684/epd.2016.0882 · Cited by 20
Lennox-Gastaut syndrome: New treatments and treatments under investigation
Auvin, S. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.01.364 · Cited by 14
General Principles of Medical Management
Perucca, E. (2009) · doi:10.1002/9781444316667.ch9 · Cited by 10
Proceedings of the 15th Antiepileptic Drug and Device Trials Meeting: State of the Science
Boada, C. M., French, J. A., & Dumanis, S. B. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2020.107189 · Cited by 10
Therapeutic Strategies for Treatment-resistant Depression: State of the Art and Future Perspectives
Goh, K. K., Chang, S.-C., Chen, C.-H., & Lu, M. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200110101604 · Cited by 8
Cited by
Knupp, K. G., Scheffer, I. E., Ceulemans, B., Sullivan, J., Nickels, K. C., Lagae, L., Guerrini, R., Zuberi, S. M., Nabbout, R., Riney, K., et al. (2023) · Epilepsia · doi:10.1111/epi.17431 · Cited by 55
Shao, E., Chang, C.-W., Li, Z., Yu, X., Ho, K., Zhang, M., Wang, X., Simms, J., Lo, I., Speckart, J., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abm5527 · Cited by 54
Bishop, K. I., Isquith, P. K., Gioia, G. A., Knupp, K. G., Scheffer, I. E., Nabbout, R., Specchio, N., Sullivan, J., Auvin, S., Helen Cross, J., et al. (2023) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2022.108994 · Cited by 43
Presynaptic antiseizure medications-basic mechanisms and clues for their rational combinations
Czapińska-Ciepiela, E. K., Łuszczki, J., Czapiński, P., Czuczwar, S. J., & Lasoń, W. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00603-7 · Cited by 13
“Some of them block voltage-gated Na + channels (VGSCs) or voltage-gated Ca 2 + channels (VGCCs), increase GABA concentra - tions, block glutamate receptors, inhibit carbonic anhydrase, activate GABA A receptors (GABA A R) r or modulate synaptic vesicles [11].”
Background
Metadata
- Authors
- Löscher, W., & Klein, P.
- Venue
- CNS Drugs
- Published
- 2021-06-18
- Volume
- 35
- Issue
- 9
- Pages
- 935-963
- ISSN
- 1172-7047 (ISSN-L)
- 1179-1934
- OpenAlex
- W3172791707
- Cited by
- 367
- References
- 163
- FWCI
- 30.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.